bromopyruvate has been researched along with acetylcysteine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nickoloff, BJ; Qin, JZ; Xin, H | 1 |
Castigli, E; Coaccioli, S; Corazzi, L; Davidescu, M; Macchioni, L; Marchetti, C; Migliorati, G; Roberti, R; Sciaccaluga, M | 1 |
Feng, X; Liu, Q; Wang, P; Wang, X; Zhang, Y | 1 |
Chavez, V; Orue, A; Rieber, M; Strasberg-Rieber, M | 1 |
4 other study(ies) available for bromopyruvate and acetylcysteine
Article | Year |
---|---|
3-Bromopyruvate induces necrotic cell death in sensitive melanoma cell lines.
Topics: Acetylcysteine; Adenosine Triphosphate; Apoptosis; Cell Line, Tumor; Glutathione; Humans; Melanoma; Membrane Potential, Mitochondrial; Necrosis; Pyruvates; Skin Neoplasms; Superoxides | 2010 |
Mitochondrial dysfunction and effect of antiglycolytic bromopyruvic acid in GL15 glioblastoma cells.
Topics: Acetylcysteine; Adenosine Triphosphate; Apoptosis; Cell Line, Tumor; Cytochromes c; Enzyme Inhibitors; Free Radical Scavengers; Glioblastoma; Glycolysis; Humans; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Membranes; Oxidation-Reduction; Proteolysis; Pyruvates; Reactive Oxygen Species | 2011 |
Energy metabolism targeted drugs synergize with photodynamic therapy to potentiate breast cancer cell death.
Topics: Acetylcysteine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Cell Survival; Deoxyglucose; Female; Free Radical Scavengers; Human Umbilical Vein Endothelial Cells; Humans; MAP Kinase Kinase 4; Mitochondrial Membranes; p38 Mitogen-Activated Protein Kinases; Photochemotherapy; Photosensitizing Agents; Pyruvates; Reactive Oxygen Species | 2014 |
Hypoxic resistance of KRAS mutant tumor cells to 3-Bromopyruvate is counteracted by Prima-1 and reversed by N-acetylcysteine.
Topics: A549 Cells; Acetylcysteine; Aza Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Drug Resistance, Neoplasm; Free Radical Scavengers; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; GTP Phosphohydrolases; Humans; Lung Neoplasms; Melanoma; Membrane Proteins; Mutation; Proto-Oncogene Proteins p21(ras); Pyruvates; Reverse Transcriptase Polymerase Chain Reaction; Tumor Suppressor Protein p53 | 2016 |